Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Stock Symbol
-
LGND on Nasdaq, LGNDZ, LGNXZ, LGNYZ, LGNZZ on OTC
John L. Lamattina - trading volume in the past year for Ligand Pharmaceuticals Inc
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
29.5K |
$3.65M |
$123.65 |
Nov 27, 2024 |
Direct |
|
|
| Non-Qualified Stock Option (right to buy) |
5.44K |
|
|
Jun 14, 2024 |
Direct |
Common Stock |
|
| Non-Qualified Stock Option (right to buy) |
0 |
|
|
Nov 27, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.